Table 2.
Summary of reported cases of association between skin and bone diseases.
| References | Skin disease | Bone disease | Study design | Cases | Main results | Possible causes |
|---|---|---|---|---|---|---|
| Wi et al. (52) | Psoriasis | Osteopenia, osteoporosis, pathological fractures | Literature review | 13 studies | Association with osteoporosis: yes 10, no 3 Inconsistent (because of small sample sizes and missing patient information): Patients with extensive psoriasis with a longer duration of psoriasis are at increased risk of osteopenia and osteoporosis. |
Systematic corticosteroids, low vitamin D levels, less physically active |
| Ogdie et al. (53) | Psoriasis and PsA | Pathological fractures (vertebrae, hip) | Longitudinal cohort study | Psoriasis (n = 158,323), PsA (n = 9,788) aged 18–89 |
PsA: all fracture aHR 1.26 (1.06–1.27), mild psoriasis: all fractures, vertebral and hip fracture: aHR 1.07 (1.05–1.10), 1.17 (1.03–1.33) and 1.13 (1.04–1.22), severe psoriasis; all fracture and vertebral fracture: aHR 1.26 (1.15–1.39) and 2.23 (1.54–3.22). | Increased prevalence of risk factors for osteoporosis and fracture (e.g., diabetes, alcohol abuse, smoking, depression, antidepressant use, corticosteroids, methotrexate, and ciclosporin) |
| Shalom et al. (51) | Chronic urticaria | Osteoporosis | A longitudinal, community-based cohort study | Chronic urticaria (n = 11,944) | The adjusted multivariate analysis demonstrated that chronic urticaria was significantly associated with a higher risk for osteoporosis (HR 1.23, 95% confidence interval 1.10–1.37, p < 0·001). | Increased mast cell numbers are associated with increased bone resorption and decreased bone formation. Female sex, systemic corticosteroids, chronic inflammation |
| Silverberg (54), | Atopic Dermatitis | Low BMD | Cross-sectional study | 3,049 children and adolescents aged 8–19 years old | Lower BMD z-score for the total femur (survey linear regression; adjusted β [95% CI]: −0.42 [0.68 to −0.16]), including trochanter (−0.29 [−0.54 to −0.05]) and femoral neck (−0.29 [−0.53 to −0.05]) and total lumbar spine (−0.31 [−0.52 to −0.11]). | Higher levels of IgE, WBC counts levels, and higher odds of 25-OH vitamin D deficiency, low calcium and alkaline phosphatase, dietary restrictions |
| Wu et al. (55) | Atopic dermatitis | Low BMD, osteopenia, osteoporosis, related fractures | Systematic review and meta-analysis | 10 studies, children and adolescents and adults, Study participants ranged from 29 to 61,065,660 |
Adults: atopic dermatitis (OR [95% CI], p-value) fracture (1.13; [1.05–1.22]; p = 0.001) Atopic dermatitis; osteoporosis (1.95; [1.18–3.23]; p = 0.009), osteopenia (1.90; [1.51–2.38]; p < 0.001) |
(1) Inflammation-induced bone loss, (2) low vitamin D levels, (3) Corticosteroids, (4) Dietary restrictions, (5) Less physical activity, (6) Depression, stress, anxiety, and sleep disturbance, (7) Obesity, cardiovascular disease, and high alcohol and tobacco consumption |
| Chovatiya and Silverberg (56) | Bullous disease (pemphigus and pemphigoid) | Osteopenia, osteoporosis, osteomalacia, pathological fractures | Cross-sectional study | Pemphigus (n = 4,506) pemphigoid (n = 8,864) |
Pemphigus;(adjusted OR [95% CI]) Osteopenia (2.20 [1.59–3.05]), osteoporosis (2.54 [2.16–2.98]), osteomalacia (29.70 [4.05–217.83]), fractures (2.04 [1.42–2.91]) Pemphigoid; (adjusted OR [95% CI]) Osteopenia (1.59 [1.06–2.41]), osteoporosis (1.38 [1.18–1.63]), fractures (1.26 [1.04–1.53]) |
Systematic and topical corticosteroids, inflammation-induced bone loss, less physical activity, low vitamin D levels |
| Hsu et al. (57) | Bullous disease (pemphigus) | Osteopenia, osteoporosis | Case–control study | Pemphigoid (n = 130), age/sex-matched controls (n = 390) |
Pemphigoid; (adjusted OR [95%CI]) osteopenia;10.07 [3.72–27.25], osteoporosis;4.19 [1.50–11.73] | Systematic corticosteroid |
Ref, reference; PsA, psoriatic arthritis; PTH, parathyroid hormone; OP, osteoporosis; BMD, bone mineral density; aHR, adjusted Hazard Ratio; OR, Odds ratio; CI, confidence intervals.